APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-based Diabetic Eye Disease Screening System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI-based Diabetic Eye Disease Screening System Market Analysis and Forecast 2026-2032

12 August 2026171 pages

Choose your research edition.

Industry ResearchAI-based Diabetic Eye Disease Screening System Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-based Diabetic Eye Disease Screening System Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal AI-based Diabetic Eye Disease Screening System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-based Diabetic Eye Disease Screening System Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-based Diabetic Eye Disease Screening System Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global AI-based Diabetic Eye Disease Screening System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI-based Diabetic Eye Disease Screening System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI-based Diabetic Eye Disease Screening System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI-based Diabetic Eye Disease Screening System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI-based Diabetic Eye Disease Screening System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI-based Diabetic Eye Disease Screening System include Remidio, Retmarker, VoxelCloud, Airdoc, Zhiyuan Huitu, IDx, LLC, Zhenhealth, Eyenuk and AEYE Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI-based Diabetic Eye Disease Screening System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI-based Diabetic Eye Disease Screening System, also provides the revenue of main regions and countries. Of the upcoming market potential for AI-based Diabetic Eye Disease Screening System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI-based Diabetic Eye Disease Screening System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI-based Diabetic Eye Disease Screening System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI-based Diabetic Eye Disease Screening System revenue, projected growth trends, production technology, application and end-user industry.

AI-based Diabetic Eye Disease Screening System Segment by Company

Remidio

Retmarker

VoxelCloud

Airdoc

Zhiyuan Huitu

IDx, LLC

Zhenhealth

Eyenuk

AEYE Health

Optomed

AI-based Diabetic Eye Disease Screening System Segment by Type

On-premise

Cloud-based

Hybrid Mode

AI-based Diabetic Eye Disease Screening System Segment by Application

General Hospitals

Ophthalmology Hospitals

Diabetes Specialty Hospitals

AI-based Diabetic Eye Disease Screening System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Diabetic Eye Disease Screening System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-based Diabetic Eye Disease Screening System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Diabetic Eye Disease Screening System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI-based Diabetic Eye Disease Screening System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI-based Diabetic Eye Disease Screening System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-based Diabetic Eye Disease Screening System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-premise Major Player Table 3. Cloud-based Major Player Table 4. Hybrid Mode Major Player Table 5. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. General Hospitals Major Player Table 7. Ophthalmology Hospitals Major Player Table 8. Diabetes Specialty Hospitals Major Player Table 9. AI-based Diabetic Eye Disease Screening System Industry Trends Table 10. AI-based Diabetic Eye Disease Screening System Industry Drivers Table 11. AI-based Diabetic Eye Disease Screening System Industry Opportunities and Challenges Table 12. AI-based Diabetic Eye Disease Screening System Industry Restraints Table 13. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI-based Diabetic Eye Disease Screening System Market Share by Region (2021-2026) Table 16. Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI-based Diabetic Eye Disease Screening System Market Share by Region (2027-2032) Table 18. Global AI-based Diabetic Eye Disease Screening System Revenue by Players (US$ Million) & (2021-2026) Table 19. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Players (2021-2026) Table 20. Global AI-based Diabetic Eye Disease Screening System Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI-based Diabetic Eye Disease Screening System Key Players Headquarters & Area Served Table 22. Global AI-based Diabetic Eye Disease Screening System Players, Product Type & Application Table 23. Global AI-based Diabetic Eye Disease Screening System Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global AI-based Diabetic Eye Disease Screening System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global AI-based Diabetic Eye Disease Screening System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026) & (US$ Million) Table 28. Global AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032) & (US$ Million) Table 29. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Type (2021-2026) Table 30. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Type (2027-2032) Table 31. Global AI-based Diabetic Eye Disease Screening System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026) & (US$ Million) Table 33. Global AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032) & (US$ Million) Table 34. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Application (2021-2026) Table 35. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Application (2027-2032) Table 36. Remidio Company Information Table 37. Remidio Business Overview Table 38. Remidio AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Remidio AI-based Diabetic Eye Disease Screening System Product Portfolio Table 40. Remidio Recent Development Table 41. Retmarker Company Information Table 42. Retmarker Business Overview Table 43. Retmarker AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Retmarker AI-based Diabetic Eye Disease Screening System Product Portfolio Table 45. Retmarker Recent Development Table 46. VoxelCloud Company Information Table 47. VoxelCloud Business Overview Table 48. VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. VoxelCloud AI-based Diabetic Eye Disease Screening System Product Portfolio Table 50. VoxelCloud Recent Development Table 51. Airdoc Company Information Table 52. Airdoc Business Overview Table 53. Airdoc AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Airdoc AI-based Diabetic Eye Disease Screening System Product Portfolio Table 55. Airdoc Recent Development Table 56. Zhiyuan Huitu Company Information Table 57. Zhiyuan Huitu Business Overview Table 58. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Portfolio Table 60. Zhiyuan Huitu Recent Development Table 61. IDx, LLC Company Information Table 62. IDx, LLC Business Overview Table 63. IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. IDx, LLC AI-based Diabetic Eye Disease Screening System Product Portfolio Table 65. IDx, LLC Recent Development Table 66. Zhenhealth Company Information Table 67. Zhenhealth Business Overview Table 68. Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Zhenhealth AI-based Diabetic Eye Disease Screening System Product Portfolio Table 70. Zhenhealth Recent Development Table 71. Eyenuk Company Information Table 72. Eyenuk Business Overview Table 73. Eyenuk AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Eyenuk AI-based Diabetic Eye Disease Screening System Product Portfolio Table 75. Eyenuk Recent Development Table 76. AEYE Health Company Information Table 77. AEYE Health Business Overview Table 78. AEYE Health AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. AEYE Health AI-based Diabetic Eye Disease Screening System Product Portfolio Table 80. AEYE Health Recent Development Table 81. Optomed Company Information Table 82. Optomed Business Overview Table 83. Optomed AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Optomed AI-based Diabetic Eye Disease Screening System Product Portfolio Table 85. Optomed Recent Development Table 86. North America AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026) & (US$ Million) Table 87. North America AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032) & (US$ Million) Table 88. North America AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026) & (US$ Million) Table 89. North America AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032) & (US$ Million) Table 90. North America AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026) & (US$ Million) Table 92. North America AI-based Diabetic Eye Disease Screening System Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe AI-based Diabetic Eye Disease Screening System Revenue by Country (US$ Million) & (2027-2032) Table 100. China AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026) & (US$ Million) Table 101. China AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032) & (US$ Million) Table 102. China AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026) & (US$ Million) Table 103. China AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia AI-based Diabetic Eye Disease Screening System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia AI-based Diabetic Eye Disease Screening System Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia AI-based Diabetic Eye Disease Screening System Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. AI-based Diabetic Eye Disease Screening System Image Figure 2. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-based Diabetic Eye Disease Screening System Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-premise Image Figure 5. Cloud-based Image Figure 6. Hybrid Mode Image Figure 7. Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global AI-based Diabetic Eye Disease Screening System Market Size Share 2021 VS 2025 VS 2032 Figure 9. General Hospitals Image Figure 10. Ophthalmology Hospitals Image Figure 11. Diabetes Specialty Hospitals Image Figure 12. Global AI-based Diabetic Eye Disease Screening System Market Size (US$ Million) & (2021-2032) Figure 13. Global AI-based Diabetic Eye Disease Screening System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI-based Diabetic Eye Disease Screening System Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global AI-based Diabetic Eye Disease Screening System Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI-based Diabetic Eye Disease Screening System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Type (2021-2032) Figure 20. Global AI-based Diabetic Eye Disease Screening System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Application (2021-2032) Figure 23. North America AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032) Figure 25. North America AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032) Figure 26. North America AI-based Diabetic Eye Disease Screening System Revenue Share by Country (2021-2032) Figure 27. United States AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032) Figure 32. Europe AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032) Figure 33. Europe AI-based Diabetic Eye Disease Screening System Revenue Share by Country (2021-2032) Figure 34. Germany AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032) Figure 44. China AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032) Figure 45. Asia AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032) Figure 47. Asia AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032) Figure 48. Asia AI-based Diabetic Eye Disease Screening System Revenue Share by Region (2021-2032) Figure 49. Japan AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032) Figure 57. SAMEA AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032) Figure 58. SAMEA AI-based Diabetic Eye Disease Screening System Revenue Share by Country (2021-2032) Figure 59. Brazil AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt AI-based Diabetic Eye Disease Screening System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • On-premise
  • Cloud-based
  • Hybrid Mode
Applications
  • General Hospitals
  • Ophthalmology Hospitals
  • Diabetes Specialty Hospitals
Companies covered
  • Remidio
  • Retmarker
  • VoxelCloud
  • Airdoc
  • Zhiyuan Huitu
  • IDx, LLC
  • Zhenhealth
  • Eyenuk
  • AEYE Health
  • Optomed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI-based Diabetic Eye Disease Screening System Market by Type
  3. 1.2.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-premise
  5. 1.2.3 Cloud-based
  6. 1.2.4 Hybrid Mode
  7. 1.3 AI-based Diabetic Eye Disease Screening System Market by Application
  8. 1.3.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 General Hospitals
  10. 1.3.3 Ophthalmology Hospitals
  11. 1.3.4 Diabetes Specialty Hospitals
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 AI-based Diabetic Eye Disease Screening System Market Dynamics
  1. 2.1 AI-based Diabetic Eye Disease Screening System Industry Trends
  2. 2.2 AI-based Diabetic Eye Disease Screening System Industry Drivers
  3. 2.3 AI-based Diabetic Eye Disease Screening System Industry Opportunities and Challenges
  4. 2.4 AI-based Diabetic Eye Disease Screening System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI-based Diabetic Eye Disease Screening System Market Perspective (2021-2032)
  2. 3.2 Global AI-based Diabetic Eye Disease Screening System Growth Trends by Region
  3. 3.2.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
  5. 3.2.3 Global AI-based Diabetic Eye Disease Screening System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Players
  2. 4.1.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Players (2021-2026)
  3. 4.1.2 Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI-based Diabetic Eye Disease Screening System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI-based Diabetic Eye Disease Screening System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI-based Diabetic Eye Disease Screening System Key Players Headquarters & Area Served
  7. 4.4 Global AI-based Diabetic Eye Disease Screening System Players, Product Type & Application
  8. 4.5 Global AI-based Diabetic Eye Disease Screening System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI-based Diabetic Eye Disease Screening System Market CR5 and HHI
  11. 4.6.3 2025 AI-based Diabetic Eye Disease Screening System Tier 1, Tier 2, and Tier 3
5 AI-based Diabetic Eye Disease Screening System Market Size by Type
  1. 5.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2032)
  3. 5.3 Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Type (2021-2032)
6 AI-based Diabetic Eye Disease Screening System Market Size by Application
  1. 6.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2032)
  3. 6.3 Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Remidio
  2. 7.1.1 Remidio Company Information
  3. 7.1.2 Remidio Business Overview
  4. 7.1.3 Remidio AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Remidio AI-based Diabetic Eye Disease Screening System Product Portfolio
  6. 7.1.5 Remidio Recent Developments
  7. 7.2 Retmarker
  8. 7.2.1 Retmarker Company Information
  9. 7.2.2 Retmarker Business Overview
  10. 7.2.3 Retmarker AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Retmarker AI-based Diabetic Eye Disease Screening System Product Portfolio
  12. 7.2.5 Retmarker Recent Developments
  13. 7.3 VoxelCloud
  14. 7.3.1 VoxelCloud Company Information
  15. 7.3.2 VoxelCloud Business Overview
  16. 7.3.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 VoxelCloud AI-based Diabetic Eye Disease Screening System Product Portfolio
  18. 7.3.5 VoxelCloud Recent Developments
  19. 7.4 Airdoc
  20. 7.4.1 Airdoc Company Information
  21. 7.4.2 Airdoc Business Overview
  22. 7.4.3 Airdoc AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Airdoc AI-based Diabetic Eye Disease Screening System Product Portfolio
  24. 7.4.5 Airdoc Recent Developments
  25. 7.5 Zhiyuan Huitu
  26. 7.5.1 Zhiyuan Huitu Company Information
  27. 7.5.2 Zhiyuan Huitu Business Overview
  28. 7.5.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Portfolio
  30. 7.5.5 Zhiyuan Huitu Recent Developments
  31. 7.6 IDx, LLC
  32. 7.6.1 IDx, LLC Company Information
  33. 7.6.2 IDx, LLC Business Overview
  34. 7.6.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 IDx, LLC AI-based Diabetic Eye Disease Screening System Product Portfolio
  36. 7.6.5 IDx, LLC Recent Developments
  37. 7.7 Zhenhealth
  38. 7.7.1 Zhenhealth Company Information
  39. 7.7.2 Zhenhealth Business Overview
  40. 7.7.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Zhenhealth AI-based Diabetic Eye Disease Screening System Product Portfolio
  42. 7.7.5 Zhenhealth Recent Developments
  43. 7.8 Eyenuk
  44. 7.8.1 Eyenuk Company Information
  45. 7.8.2 Eyenuk Business Overview
  46. 7.8.3 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eyenuk AI-based Diabetic Eye Disease Screening System Product Portfolio
  48. 7.8.5 Eyenuk Recent Developments
  49. 7.9 AEYE Health
  50. 7.9.1 AEYE Health Company Information
  51. 7.9.2 AEYE Health Business Overview
  52. 7.9.3 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 AEYE Health AI-based Diabetic Eye Disease Screening System Product Portfolio
  54. 7.9.5 AEYE Health Recent Developments
  55. 7.10 Optomed
  56. 7.10.1 Optomed Company Information
  57. 7.10.2 Optomed Business Overview
  58. 7.10.3 Optomed AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Optomed AI-based Diabetic Eye Disease Screening System Product Portfolio
  60. 7.10.5 Optomed Recent Developments
8 North America
  1. 8.1 North America AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
  2. 8.2 North America AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2032)
  3. 8.2.1 North America AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026)
  4. 8.2.2 North America AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032)
  5. 8.3 North America AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032)
  6. 8.4 North America AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2032)
  7. 8.4.1 North America AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026)
  8. 8.4.2 North America AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032)
  9. 8.5 North America AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032)
  10. 8.6 North America AI-based Diabetic Eye Disease Screening System Revenue by Country
  11. 8.6.1 North America AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026)
  13. 8.6.3 North America AI-based Diabetic Eye Disease Screening System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
  2. 9.2 Europe AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032)
  5. 9.3 Europe AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032)
  9. 9.5 Europe AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI-based Diabetic Eye Disease Screening System Revenue by Country
  11. 9.6.1 Europe AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI-based Diabetic Eye Disease Screening System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
  2. 10.2 China AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2032)
  3. 10.2.1 China AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026)
  4. 10.2.2 China AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032)
  5. 10.3 China AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032)
  6. 10.4 China AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2032)
  7. 10.4.1 China AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026)
  8. 10.4.2 China AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032)
  9. 10.5 China AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
  2. 11.2 Asia AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032)
  5. 11.3 Asia AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032)
  9. 11.5 Asia AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI-based Diabetic Eye Disease Screening System Revenue by Country
  11. 11.6.1 Asia AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI-based Diabetic Eye Disease Screening System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI-based Diabetic Eye Disease Screening System Revenue (2021-2032)
  2. 12.2 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI-based Diabetic Eye Disease Screening System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI-based Diabetic Eye Disease Screening System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country
  11. 12.6.1 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI-based Diabetic Eye Disease Screening System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst